Alembic Pharma gets tentative USFDA nod for breast cancer drug Ribociclib in March Quarter Ruchika Sharma2 April 2024 3:17 PM ISTVadodara: Alembic Pharma has informed in a BSE filing that the Company has received tentative approval for Ribociclib Tablets, 200 mg,...
AstraZeneca Truqap plus Faslodex gets nod in Japan for advanced HR-positive breast cancer Ruchika Sharma31 March 2024 2:30 PM ISTCambridge: AstraZeneca's Truqap (capivasertib) in combination with Faslodex (fulvestrant) has been approved in Japan for the treatment of adult...
AstraZeneca India bags dual CDSCO nod for Trastuzumab deruxtecan Ruchika Sharma28 March 2024 1:30 PM ISTBangalore: AstraZeneca Pharma India Limited has received permission to import for sale and distribution of Trastuzumab deruxtecan lyophilized...
Medical AI tool uncovers breast cancer signs in 11 women that doctors overlooked Roshni Dhar27 March 2024 5:44 PM ISTIn a groundbreaking advancement for cancer detection, a medical AI tool named Mia has emerged as a potential game-changer in the fight against breast...
Adding ribociclib to hormone therapy reduces the risk of breast cancer recurrence: NEJM Dr. Kamal Kant Kohli26 March 2024 11:15 PM ISTA new treatment approach that combines a targeted therapy drug with hormone therapy significantly increased the amount of time a person with stage 2...
Health Bulletin 26/ March/ 2024 Roshni Dhar26 March 2024 4:55 PM ISTHere are the top health news for the day:A Microsoft-powered medical AI spotted cancer in 11 women where doctors didn'tIn a groundbreaking advancement...
Combined PET-MRI scan could improve treatment for patients with early breast cancer: Study Dr. Kamal Kant Kohli24 March 2024 8:00 PM ISTUsing a combined scanning technique on patients with early-stage breast cancer improved treatment in almost three out of ten cases in a trial...
Mammography-based AI model can predict 5-year breast cancer risk: Study Medha Baranwal21 March 2024 11:30 PM ISTUSA: Duke University researchers have developed an artificial intelligence (AI) model that can predict five-year breast cancer risk from mammograms,...
Annual mammography with clinical exam is "likely sufficient" than semiannual after breast-conserving surgery: Study Medha Baranwal20 March 2024 8:00 PM ISTUSA: A recent study found that evidence is insufficient to support semi-annual mammography in the early postoperative period after breast-conserving...
Dr Reddys Labs unveils Versavo in UK for several types of cancers Ruchika Sharma20 March 2024 2:30 PM ISTHyderabad: Dr Reddy's Laboratories Ltd., a global pharmaceutical company, has announced the launch of Versavo (bevacizumab) in the United Kingdom...
Radiation therapy in breast cancer linked to increased risk of melanoma and hemangiosarcoma: JAMA Dr Riya Dave11 March 2024 8:00 PM ISTPrevious studies have suggested a potential link between radiation therapy for breast cancer and an increased risk of subsequent nonkeratinocyte skin...
EMA validates marketing authorisation applications for AstraZeneca, Daiichi Sankyo datopotamab deruxtecan in lung, breast cancer Ruchika Sharma6 March 2024 3:25 PM ISTCambridge: The European Medicines Agency (EMA) has validated two marketing authorisation applications (MAAs) for AstraZeneca and Daiichi Sankyo’s...
